Group by Josh Universe. This group is dedicated to the advancement and interdisciplinary exchange of knowledge within the fields of regenerative medicine, human longevity, stem cell therapies, gene editing, and cognitive enhancement. It serves as a professional space for researchers, clinicians, biotech entrepreneurs, longevity enthusiasts, and translational scientists to share findings, discuss clinical applications, and explore ethical implications in emerging biotechnologies.

Key topics include tissue engineering, cellular rejuvenation, age-related disease interventions, CRISPR and epigenetic reprogramming, neural regeneration, and the development and responsible use of nootropics. The group encourages evidence-based discussion on therapeutic strategies aimed at extending healthspan, reversing biological aging, and enhancing human cognitive function.

Members are welcome to share peer-reviewed articles, clinical trial developments, case studies, novel startup efforts, and policy discussions. The aim is to bridge scientific rigor with real-world application, promoting collaboration among academia, industry, and regulatory perspectives.

regenerative medicine, longevity biotech, stem cells, gene therapy, anti-aging research, cell reprogramming, neurogenesis, telomere biology, tissue engineering, aging reversal, CRISPR, senescence, epigenetic therapy, nootropics, healthspan optimization, life extension, neural enhancement, biotech startups, aging biomarkers, mRNA therapy, cell therapy companies, Aubrey de Grey, Altos Labs, Calico Labs, Rejuvenate Bio, BioAge Labs, Lifespan.io, SENS Research Foundation, mitochondrial rejuvenation, personalized longevity, cellular therapies, translational aging science.